110331 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Gammaretrovirus, e.g. murine leukeamia virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
#2ENGINEERED VIRUS
#3SARS-COV-2 POLYPEPTIDE, ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF
#4CHARACTERIZATION AND INACTIVATION OF ENDOGENOUS RETROVIRUSES IN CHINESE HAMSTER OVARY CELLS
#5COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#6PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMYELINATING DISEASES CONTAINING SUPERNATANT OF IMMORTALIZED MESENCHYMAL STEM CELLS, AND PHARMACEUTICAL PREPARATION CONTAINING SAME COMPOSITION AS ACTIVE INGREDIENT
#7COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#8COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#9CYTOMEGALOVIRUS VECTORS AND METHODS OF USE
#10SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF PRIME EDITORS AND METHODS OF MAKING AND USING SAME
#11COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#12KOALA RETROVIRUS ENVELOPE GYLCOPROTEINS AND USES THEREOF
#13RECOMBINANT NEWCASTLE DISEASE VIRUS (rNDV) VECTORS AND METHODS OF USING THE SAME
#14ONCOLYTIC VIRUS STRAIN
#15MODIFIED ONCOLYTIC VIRUS
#16Modified Marek's disease virus, and vaccines made therefrom
#17Plasmid system
#18ENGINEERED VIRUS
#19MODIFIED ONCOLYTIC VIRUS
#20Oncolytic virus strain
#21CELL-TO-CELL DELIVERY OF RNA CIRCUITS
#22ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS
#23MODIFIED ENVELOPE GLYCOPROTEINS FOR RETROVIRIDAE VIRAL VECTOR PSEUDOTYPING AND PROCESS FOR OBTAINING IT
#24CHARACTERIZATION AND INACTIVATION OF ENDOGENOUS RETROVIRUSES IN CHINESE HAMSTER OVARY CELLS
#25Dimeric reverse transcriptase
#26Engineered virus
#27IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
#28DELIVERY OF A GENE-EDITING SYSTEM WITH A SINGLE RETROVIRAL PARTICLE AND METHODS OF GENERATION AND USE
#29Oncolytic virus strain
#30Modified oncolytic virus
#31DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS
#32Dimeric reverse transcriptase
#33Genome editing reagents and their use
#34POLYPEPTIDES FOR ENGINEERING INTEGRASE CHIMERIC PROTEINS AND THEIR USE IN GENE THERAPY
#35Modified Marek's disease virus, and vaccines made therefrom
#36Oncolytic virus strain
#37Engineered virus
#38Use of an oncolytic virus for the treatment of cancer
#39Modified oncolytic virus
#40Vaccine compositions for treatment of Zika virus
#41Recombinant vectors comprising 2A peptide
#42Gene therapy vector system and prodrug genes
#43Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
#44Dimeric reverse transcriptase
#45Feline leukemia virus trans-membrane protein p15E for diagnosis of FeLV infection
#46Delivery of packaged RNA to mammalian cells
#47Method for producing enveloped viruses
#48Delivery of packaged RNA to mammalian cells
#49Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#50Lentiviral vectors pseudotyped with mutant BaEV glycoproteins
#51Lipoparticles comprising proteins, methods of making, and using the same
#52Chimeric glycoproteins and pseudotyped lentiviral vectors
#53Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#54Gammaretrovirus Associated With Cancer
#55Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#56Markers of XMRV Infection And Uses Thereof
#57Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#58Method for the production of antibodies that bind to multiple membrane spanning proteins
#59MARKERS OF XMRV INFECTION AND USES THEREOF
#60Identification of a novel retrovirus in patients with benign prostatic hyperplasia
#61TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS
#62FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#63METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS
#64Method for Producing Stable Mammalian Cell Lines Producing High Levels of Recombinant Proteins
#65Markers of XMRV infection and uses thereof
#66Markers of XMRV Infection and Uses Thereof
#67Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#68METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#69Trimerizing polypeptides
#70METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#71Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
#72Gammaretrovirus associated with cancer
#73Chimeric influenza virus-like particles
#74CHIMERIC VIRUS-LIKE PARTICLES
#75Virus coated nanoparticles and uses thereof
#76MOLECULAR SEQUENCE OF SWINE RETROVIRUS AND METHODS OF USE
#77TSG101-GAG INTERACTION AND USE THEREOF
#78High-throughput assay for virus entry and drug screening
#79Retroviral vector
#80USE OF RECOMBINANT ANTIGENS TO DETERMINE THE IMMUNE STATUS OF AN ANIMAL
#81Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#82Compositions and Methods for Elimination of Unwanted Cells
#83Compositions and Methods for Elimination of Unwanted Cells
#84Trimerizing polypeptides
#85COMPLEX
#86Immunodeficiency recombinant poxvirus
#87Compositions and Methods for Elimination of Unwanted Cells
#88Compositions and methods for elimination of unwanted cells
#89Methods of inducing mucosal immunity
#90Novel compositions and methods in cancer
#91Cancer cell targeting gene delivery method
#92Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#93Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#94Stable retrovirus and methods of use
#95Materials and methods relating to fusion proteins for inducing an immune response
#96Self-inactivating retroviral vector
#97Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#98Stabilized immunogenic HBc chimer particles
#99Retroviral vector
#100Chimeric glycoproteins and pseudotyped lentiviral vectors
#101Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
#102Compositions and methods for delivery of genetic material
#103Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#104Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
#105Compositions and methods for elimination of unwanted cells
#106Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#107Needle-free administration of FeLV vaccines
#108Packaging cells
#109Method of delivering therapeutic agents to site of tissue injury
#110Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice
#111High-throughput assay for virus entry and drug screening
#112Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein
#113Lipoparticles comprising proteins, methods of making, and using the same
#114Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
#115Marek's disease virus vaccine
#116Vaccine compositions for treatment of Zika virus